Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis

Published:2010-10-14 Issue:15 Volume:116 Page:2857-2858
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Passamonti Francesco¹,Cervantes Francisco²,Vannucchi Alessandro Maria³,Morra Enrica⁴,Rumi Elisa¹,Cazzola Mario¹,Tefferi Ayalew⁵

Affiliation:

1. Division of Hematology, Department of Hematology Oncology, University of Pavia & Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

2. Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain

3. UF di Ematologia, Dip. Area Critica Medico-Chirugica, Università di Firenze; Istituto Toscano Tumori, Firenze, Italy

4. Division of Hematology, Ospedale Niguarda Ca' Granda, Milan, Italy

5. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/116/15/2857/1331261/zh804110002857.pdf

Reference10 articles.

1. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.;Mesa;Blood,2005

2. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.;Thoennissen;Blood,2010

3. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.;Cervantes;Blood,2009

4. The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course.;Tam;Blood,2009

5. Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients.;Morel;Blood,2010

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.);Clinical Oncohematology;2024-07-01

2. Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT;Bone Marrow Transplantation;2024-03-15

3. Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study;Annals of Hematology;2024-03-13

4. Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study;Leukemia;2024-02-06

5. The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective;Leukemia Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3